Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

that was my concern when i heard about a few investors/ihub contributors helping to advance discussions of brilacidin with potential influential people. i don't understand how these few individuals would have more information then what has been publicly disclosed... even the long disputed rbl and phri names. It seemed obvious because of previous connections and the june 5th announcement, but at no point prior to the latest pr did IPIX ever mention gmu (or rutgers)

i have been down the ihub/otc road before where a few have privileged info making them more or less consultants of the company as compared to individual investors posting to a public blog. not saying that is the case here, but has been my experience

still bullish with the pre-print finally posted and the fda pre-print ind comments in. Next step seems announcing the formal ind submitted and a trial start date (and potential naming of hospitals/locations recruiting the 120 patients) as well as when interim analysis will be conducted

The company's message was about saving lives in their last pr